FDA Inspection
We are BloodWe are Blood – FDA Inspection, Oct 7, 2019
Record Details
This FDA Inspection record concerns We are Blood, with an inspection on October 7, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- We are Blood
- Inspection Date
- October 7, 2019
- Product Type
- Biologics
View Company Profile
ID · d217ecee-13c4-4b2b-bd17-d7b65957ec8b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1105456
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of We are Blood
7| Date | Classification | Office | Project area |
|---|---|---|---|
| October 24, 2023 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 5, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 20, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 21, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 13, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for We are Blood
- FDA Inspection 1221114 - 2023-10-24
- FDA Inspection 1055674 - 2018-06-05
- FDA Inspection 986832 - 2016-09-20
- FDA Inspection 887907 - 2014-07-21
- FDA Inspection 807003 - 2012-11-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.